Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05380167 · ClinicalTrials.gov registry record · NA

Efficacy Long-term Dietary Nitrate Consumption to Plasma Nitrite Conversion

A NA study, sponsored by Wake Forest University.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT05380167: Completed NA study, sponsored by Wake Forest University.

NCT05380167 is a NA study that has completed, run by Wake Forest University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05380167, a NA study, has completed, sponsored by Wake Forest University.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The objective of this study was to determine the chronic effects of beetroot juice supplementation on the acute (90-minute post nitrate consumption) efficacy of converting dietary nitrate to plasma nitrate and plasma nitrite in healthy middle-to-older aged adults. the investigators were also interested in determining the effect of this intervention on fasting levels of plasma nitrate and nitrite over time. Furthermore, the number of participants classified as "non-responders" was determined based on increases in plasma nitrite achieved using tolerable volumes of beetroot juice by other studies.

Primary Outcome

Concentration of nitrate in the plasma obtained at the start of each testing visit

Interventions

  • DIETARY_SUPPLEMENT BRJ Nitrate
  • DIETARY_SUPPLEMENT BRJ Placebo

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2017-09-01
Est. Completion 2019-05-01
Phase NA
Wake Forest University

100 total trials

What the finished NCT05380167 record still lists

NCT05380167 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which BRJ Nitrate is the first listed.

NCT05380167 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05380167 about?

NCT05380167 is a clinical study titled "Efficacy Long-term Dietary Nitrate Consumption to Plasma Nitrite Conversion". The objective of this study was to determine the chronic effects of beetroot juice supplementation on the acute (90-minute post nitrate consumption) efficacy of converting dietary nitrate to plasma nitrate and plasma nitrite in healthy middle-to-older aged adults. the investigators were also interes...

What is the current status of trial NCT05380167?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2017-09-01. Estimated completion is 2019-05-01.

What interventions are being tested in trial NCT05380167?

The interventions under investigation include: BRJ Nitrate (DIETARY_SUPPLEMENT), BRJ Placebo (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05380167?

This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05380167's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05380167, the US trial registry maintained by the National Library of Medicine. NCT05380167 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.